In patients with a mild form of SCH, after 6 months of levothyroxine treatment and previously established euthyroidism, we observed a significant decrease in endocan and CHOL concentrations, while in SCH patients without levothyroxine therapy, we observed an increase in ET-1 concentration after a follow-up of 6 months. Here, EDN1 is linked to spindle cell hemangioma.